$PLPL Announces USN Developing New Products Using Phytofare(R)

 Plandaí Biotechnology, Inc. (PLPL) (“Plandaí” or “the Company”), producer of the highly bioavailable Phytofare^® catechin complex, today announced that Ultimate Sports Nutrition (USN) is investigating and developing a new line of products for the Australian and New Zealand markets that incorporates Plandaí’s green tea catechin-based Phytofare^® ingredient. Under the terms of a previously announced agreement, USN is committed to using Phytofare^® catechin complex exclusively in all products manufactured or sold in Europe and South Africa that incorporate green tea. In an effort to further develop and expand on the existing agreement, the Company and USN agreed to allow USN to explore the use of Phytofare^® with other USN contract manufacturers, beginning in Australia and New Zealand, in an attempt to determine whether further expansion of the relationship between the Company and USN was desirable.

Callum Baylis-Duffield, Vice President of Sales and Marketing for Plandaí, commented, “USN has really embraced the benefits of phyto-availability™ in their quest to deliver the absolute best quality products to their customers. Phytofare^® delivers more of the active ingredients to the blood stream where those ingredients then remain in the system at functional levels much longer than generic supplements. This phyto-availability™ translates into noticeable results to consumers. Seeing how quickly USN has expanded their use of Phytofare® outside of South Africa into Europe and now being the focus of new product development in the Australian continent is encouraging both from a sales standpoint and as a validation that consumers are starting to require performance from their supplements.”

USN (www.usn.co.za) was founded in South Africa in 2000, and it remains a comprehensive health and nutrition supplement brand, driving the forefront of sports nutrition globally. Rapid expansion and an increasing consumer base have been realized through a commitment to leading product innovation, the highest quality raw material suppliers globally, premium manufacturing facilities and excellent customer support on all levels. All products are formulated with the backing of extensive research and scientific findings, as well as the important clinical trials to ensure efficacy and safety. USN continues its global growth strategy, and it is now being sold in pharmacies, FMCG and specialist retailers in over 53 countries on four continents.

Under the terms of the revised three-year agreement, USN has agreed to use Phytofare^® as the exclusive green-tea ingredient in their manufactured supplements in South Africa and the European Union exchange for guaranteed pricing and availability concessions from Plandaí.

About Plandaí Biotechnology, Inc.

Plandaí Biotechnology, Inc. and its subsidiaries develop highly phyto-available extracts. Plandaí Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its proprietary Phytofare^® extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company’s products include beverage, cosmeceutical, wellness, nutriceutical, anti-aging, and pharmaceutical. For more information, please visithttps://www.plandaibiotech.com.

Safe Harbor Statement

This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project” or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Readers are advised to review our filings with the Securities and Exchange Commission that can be accessed over the Internet at the SEC’s website located at https://www.sec.gov.